Navigation Links
Reportlinker Adds Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Date:4/12/2011

NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

http://www.reportlinker.com/p0480069/Continuous-Glucose-Monitoring-CGM-Systems---Global-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Summary

GlobalData's new report, "Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global Continuous Glucose Monitoring (CGM) systems market. The report provides market landscape, competitive landscape and market trends information on the Continuous Glucose Monitoring (CGM) systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, China, India, and Australia.

- Annualized market revenues data from 2005 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within Continuous Glucose Monitoring (CGM) systems market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Medtronic, DexCom and Abbott Laboratories.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the Continuous Glucose Monitoring (CGM) systems market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the Continuous Glucose Monitoring (CGM) systems market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global Continuous Glucose Monitoring (CGM) systems market and the factors shaping it.

1 Table of contents

1 Table of contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 GlobalData Report Guidance 6

3 Disease Overview 7

3.1 Diabetes 7

3.2 Epidemiology 7

4 Continuous Glucose Monitoring (CGM) Systems – Overview 9

4.1 Cost Analysis for CGM Systems 9

5 Continuous Gluose Monitoring Systems – Market Characterization 10

5.1 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Historic, 2005–2009 10

5.2 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Forecast, 2009-2016 11

5.3 Continuous Glucose Monitoring Systems, Market Dynamics 12

5.3.1 Continuous Glucose Monitoring Systems, Market Drivers 12

5.3.2 Continuous Glucose Monitoring Systems, Market Restraints 14

6 Continuous Glucose Monitoring Systems Market, by Country, Revenue ($m), 2005-2016 16

6.1 Continuous Glucose Monitoring Systems Market, US, Revenue ($m), Historic, 2005–2009 16

6.2 Continuous Glucose Monitoring Systems Market, US, Revenue ($m), Forecast, 2009–2016 17

6.3 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), Historic, 2006–2009 18

6.4 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), Forecast, 2009–2016 19

6.5 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), Historic, 2007–2009 20

6.6 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), Forecast, 2009–2016 21

6.7 Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), Historic, 2008–2009 22

6.8 Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), Forecast, 2009–2016 23

6.9 Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), Historic, 2007–2009 24

6.10 Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), Forecast, 2009–2016 25

6.11 Continuous Glucose Monitoring Systems Market, Italy, Revenue ($000s), Historic, 2008–2009 26

6.12 Continuous Glucose Monitoring Systems Market, Italy, Revenue ($m), Forecast, 2009–2016 27

6.13 Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), Historic, 2005–2009 28

6.14 Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), Forecast, 2009–2016 29

6.15 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), Historic, 2007–2009 30

6.16 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), Forecast, 2009–2016 31

6.17 Continuous Glucose Monitoring Systems Market, China, Revenue ($m), Historic, 2005–2009 32

6.18 Continuous Glucose Monitoring Systems Market, China, Revenue ($m), Forecast, 2009–2016 33

6.19 Continuous Glucose Monitoring Systems Market, India, Revenue ($m), Historic, 2005–2009 34

6.20 Continuous Glucose Monitoring Systems Market, India, Revenue ($m), Forecast, 2009–2016 35

6.21 Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), Historic, 2005–2009 36

6.22 Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), Forecast, 2009–2016 37

7 Continuous Glucose Monitoring Systems, Global, Key Company Shares 38

7.1 Continuos Glucose Monitoring Systems: Key Market Participants 39

7.1.1 Medtronic, Inc. 39

7.1.2 DexCom, Inc. 40

7.1.3 Abbott Diabetes Care, Inc. (Subsidiary of Abbott Laboratories) 41

8 Key Continuous Glucose Monitoring Systems in the Market 42

8.1 Abbott FreeStyle Navigator 42

8.1.1 Overview 42

8.1.2 Clinical Trial Details 42

8.2 Medtronic's MiniMed Paradigm REAL-Time System 43

8.2.1 Overview 43

8.3 Medtronic's MiniMed Guardian REAL-Time System 44

8.3.1 Overview 44

8.4 DexCom SEVEN PLUS 44

8.4.1 Overview 44

9 Continuous Glucose Monitoring Systems Market, Pipeline Assessment 45

9.1 Profiles of Promising Continuous Glucose Monitoring Systems Under Clinical Development 46

9.1.1 EyeSense Blood Glucose Measurement Device 46

9.1.2 HypoMon 47

9.1.3 MicroEye 49

9.1.4 NBM-200G 49

9.1.5 Optical Hypoglycemia Detector 51

9.1.6 OptiScanner 5000 51

9.1.7 Glucoday S 53

9.1.8 iGlyko system 55

10 Global Continuous Glucose Monitoring Systems Market: – Strategic Deals Analysis 59

10.1 Key Deals 59

10.1.1 Bayer HealthCare AG, a Subsidiary of Bayer AG, Completed the Acquisition of iSense Corporation 59

11 Appendix 60

11.1 Definitions 61

11.1.1 Continuous Glucose Monitoring Systems 61

11.2 Acronyms 61

11.3 Sources 62

11.4 Research Methodology 62

11.5 Secondary Research 63

11.6 Primary Research 63

11.7 Models 63

11.8 Forecasts 64

11.9 Expert Panels 64

11.10 GlobalData Consulting 64

11.11 Contact Us 64

11.12 Disclaimer 64

1.1 List of Tables

Table 1: Diabetes, Major Countries, Estimated Prevalence (Million), 2010 and 2030 8

Table 2: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2005–2009 10

Table 3: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2009–2016 11

Table 4: Disposable Income, Emerging Countries ($), (2002-2008) 14

Table 5: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2005–2009 16

Table 6: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2009–2016 17

Table 7: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2006–2009 18

Table 8: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2009–2016 19

Table 9: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2007–2009 20

Table 10: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2009–2016 21

Table 11: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2008–2009 22

Table 12: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2009–2016 23

Table 13: Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), 2007–2009 24

Table 14: Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), 2009–2016 25

Table 15: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($000s), 2008–2009 26

Table 16: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($m), 2009–2016 27

Table 17: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), 2005–2009 28

Table 18: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), 2009–2016 29

Table 19: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2007–2009 30

Table 20: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2009–2016 31

Table 21: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2005–2009 32

Table 22: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2009–2016 33

Table 23: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2005–2009 34

Table 24: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2009–2016 35

Table 25: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), 2005–2009 36

Table 26: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), 2009–2016 37

Table 27: Continuous Glucose Monitoring Systems Market, Global, Key Company Share, Revenue ($m), 2009 38

Table 28: Medtronic, Inc. Marketed Products, 2010 39

Table 29: Medtronic, Inc. Pipeline Products, 2010 39

Table 30: DexCom, Marketed Products, 2010 40

Table 31: DexCom, Pipeline Products, 2010 40

Table 32: Abbott Diabetes Care, Marketed Products, 2010 41

Table 33: Abbott FreeStyle Navigator, Features and Benefits 42

Table 34: MiniMed Paradigm REAL-Time System, Features and Benefits 43

Table 35: MiniMed Guardian REAL-Time System, Features and Benefits 44

Table 36: DexCom SEVEN PLUS, Features and Benefits 44

Table 37: Pipeline Technology Assessment for Continuous Glucose Monitoring by Development Stage, Global 45

Table 38: Investigation of a Sub-Conjunctival Insert 46

Table 39: EyeSense Blood glucose measurement device, Product Status, 2010 47

Table 40: Clinical Evaluation of a Non-invasive Alarm System HypoMon for Nocturnal Hypoglycemia 48

Table 41: HypoMon, Product Status, 2010 48

Table 42: MicroEye, Product Status, 2010 49

Table 43: Clinical Trial to Measure Safety, Accuracy And Efficacy Of NBM-200G in Glucose Monitoring 50

Table 44: NBM-200G, Product Status, 2010 50

Table 45: Optical Hypoglycemia Detector, Product Status, 2010 51

Table 46: Evaluation Of A Mid-Infrared Glucose Monitor On Critically Ill Patients 52

Table 47: OptiScanner 5000 , Product Status, 2010 53

Table 48: Evaluation of Different Techniques for Subcutaneous Glucose Monitoring in Type 1 Diabetic Patients During Real-Life Glucose Excursions 54

Table 49: Glucoday S, Product Status, 2010 54

Table 50: iGlyko system, Product Status, 2010 55

Table 51: Continuous Glucose Monitoring Systems (Non-Invasive Systems), Pipeline Summary, 2010 56

Table 52: Continuous Glucose Monitoring Systems (Minimally Invasive Systems), Pipeline Summary, 2010 57

Table 53: Continuous Glucose Monitoring Systems, Pipeline Summary, 2010 58

1.2 List of Figures

Figure 1: Diabetes, Major Countries, Estimated Prevalence (Million), 2010 and 2030 7

Figure 2: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2005–2009 10

Figure 3: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2009–2016 11

Figure 4: Continuous Glucose Monitoring Systems Market, Drivers and Restraints 12

Figure 5: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2005–2009 16

Figure 6: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2009–2016 17

Figure 7: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2006–2009 18

Figure 8: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2009–2016 19

Figure 9: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2007–2009 20

Figure 10: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2009–2016 21

Figure 11: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2008–2009 22

Figure 12: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2009–2016 23

Figure 13: Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), 2007–2009 24

Figure 14: Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), 2009–2016 25

Figure 15: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($000s), 2008–2009 26

Figure 16: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($m), 2009–2016 27

Figure 17: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), 2005–2009 28

Figure 18: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), 2009–2016 29

Figure 19: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2007–2009 30

Figure 20: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2009–2016 31

Figure 21: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2005–2009 32

Figure 22: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2009–2016 33

Figure 23: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2005–2009 34

Figure 24: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2009–2016 35

Figure 25: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), 2005–2009 36

Figure 26: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), 2009–2016 37

Figure 27: Continuous Glucose Monitoring Systems Market, Global, Key Company Share (%), 2009 38

Figure 28: Key Continuous Glucose Monitoring Systems in the Market 42

Figure 29: Pipeline Technology Assessment for Continuous Glucose Monitoring by Development Stage, Global 45

To order this report:

: Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... On Dec. ... the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have ... (MPNs) by going above and beyond the standard of care, demonstrating leadership within the ...
(Date:12/2/2016)... ... ... Advanced Inc., a leading provider of travel therapy and travel nursing across ... Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as Vice ... leadership experience to Advanced Inc. He began his career in finance at Ernst & ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... interview of two ostomy patients, standing as living proof that attitude and determination ... digestive diseases and issues that spike around the holidays. This campaign will offer ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized ... fulfilling lives. “We are prolonging life 6 years in the last 3 decades,” ...
Breaking Medicine News(10 mins):